-
Mashup Score: 10Meeting News | Blood Cancers Today - 5 hour(s) ago
The online home of the latest conference coverage and meeting news for hematologic oncologists. View the latest news on Blood Cancers Today.
Source: bloodcancerstoday.comCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 0User account | Research To Practice - 3 day(s) ago
Research To Practice requires users to log in to view educational content. All content is available without
Source: www.researchtopractice.comCategories: General Medicine News, Hematologists1Tweet-
Check out this episode of our podcast where Dr Neil Love moderates a roundtable discussion about paroxysmal nocturnal hemoglobinuria. https://t.co/sUSwZs1RSN https://t.co/HPHIJa5IaG
-
-
Mashup Score: 0User account | Research To Practice - 5 day(s) ago
Research To Practice requires users to log in to view educational content. All content is available without
Source: www.researchtopractice.comCategories: General Medicine News, Hematologists1Tweet-
Check out this episode of our podcast where Dr Neil Love moderates a roundtable discussion about paroxysmal nocturnal hemoglobinuria. https://t.co/sUSwZs1RSN https://t.co/HPHIJa5IaG
-
-
Mashup Score: 58BCR‐ABL testing in the evaluation of neutrophilia - 8 day(s) ago
The American Journal of Hematology publishes research in blood diseases in humans & animal model, covering all hematological diseases including leukemia, hemostasis and thrombosis.
Source: onlinelibrary.wiley.comCategories: General Medicine News, Hematologists1Tweet-
“ Patients with an ANC <20.0, who do not have basophilia or circulating myeloid precursors should not receive BCR/ABL testing as part of routine neutrophilia evaluation” https://t.co/7ICruwlzYL
-
-
Mashup Score: 0User account | Research To Practice - 10 day(s) ago
Research To Practice requires users to log in to view educational content. All content is available without
Source: www.researchtopractice.comCategories: General Medicine News, Hematologists1Tweet-
Check out this episode of our podcast where Dr Neil Love moderates a roundtable discussion about paroxysmal nocturnal hemoglobinuria. https://t.co/sUSwZs1RSN https://t.co/HPHIJa5IaG
-
-
Mashup Score: 1Siri, what is a "healthcare provider"? - 11 day(s) ago
A few sentences to make your blood boiling in this whopper from Noah Smith: It’s mostly the providers overcharging you, not the middlemen. […] the Kaiser Family Foundation does detailed comparisons between U.S. health care spending and spending in other developed countries. And it has concluded that most of this excess spending comes from providers — from hospitals, pharma companies, doctors, nurses, tech suppliers, and so on.
Source: blog.miljko.orgCategories: General Medicine News, Hematologists1Tweet-
Today in suitcase terms… https://t.co/PdbffNgoSv
-
-
Mashup Score: 3MEDVASC - Obésité et les antithrombotiques - 11 day(s) ago
Blog du Dr Jean-Pierre LAROCHE, médecin vasculaire sans filtre et pragmatique qui parle de Médecine Vasculaire et de l’actualité
Source: medvasc.infoCategories: General Medicine News, Hematologists1Tweet-
RT @Echoraljpangio: Obésité et les antithrombotiques https://t.co/MXwrAUaFbn @gilles_dl @DitesmoiVous @DJARSOccitanie @doingnz @ant_diard @…
-
-
Mashup Score: 3High5 Oncology TV: ASH 2024 - 12 day(s) ago
Für den erfolgreichen Abschluss der Fortbildungsmodule ist die korrekte (mind. 70%) Beantwortung der Lernerfolgskontrolle für das jeweilige Modul verpflichtend. Jetzt gleich den Fragebogen ausfüllen! Durch die Eingabe Ihrer individuellen einheitlichen Fortbildungsnummer (EFN) können Sie CME Fortbildungspunkte sammeln. Die bayrische Landesärztekammer erkennt dabei in jedem Fortbildungsmodul pro 45 min Videoeinheit 2 CME Punkte an. Maximal sind pro Fortbildungsmodul 4 CME Punkte möglich. Für den erfolgreiche
Source: high5oncology.tvCategories: General Medicine News, Hematologists1Tweet-
RT @high5md: Our coverage of #ASH24 is live! https://t.co/grtaVGiBj3 Discover all new study results on #hematology now, reported by expert…
-
-
Mashup Score: 0
Patients with CAR-19 progressing large B-cell lymphoma had durable remissions and long-term survival on treatment with firicabtagene autoleucel, in a phase 1 clinical trial.
Source: bloodcancerstoday.comCategories: General Medicine News, Hematologists1Tweet-
☑️ Patients with CAR-19 progressing large B-cell #lymphoma had durable remissions and long-term survival on firicabtagene autoleucel treatment. 💡 Learn more from the study presented at #ASH24 by Anne Marijn Kramer, MD, PhD (@CancerCenterAms). ➡️ https://t.co/VyiiW6cl9M https://t.co/8ExNIIx0Oj
-
-
Mashup Score: 37
New statistics from Health Quality Ontario show the average wait time for a first assessment by a doctor in the ER was 4.3 hours at CHEO in October, up from 4.1 hours in September and 2.7 hours in August.
Source: ottawa.ctvnews.caCategories: General Medicine News, Hematologists1Tweet-
RT @ctvottawa: This Ottawa hospital has the longest ER wait time to see a doctor in Ontario https://t.co/GGHidI3rVr
-
Our BCT editors are already gearing up for #ASH23, happening from December 9-12 in San Diego! @ASH_hematology Stay updated on meeting news here: https://t.co/4NzzFccn6P What are you most looking forward to at ASH? Share below! ⬇️ ⬇️ https://t.co/GtxlBVTu3P